Bausch Health Companies Inc. announced on October 28, 2026, via an 8-K press release, that its subsidiary Bausch Health Americas, Inc. will redeem approximately $643 million in aggregate principal amount of its outstanding 8.500% Senior Notes due 2027, with a redemption date of November 30, 2026.

Key Highlights

  • Redemption amount: Approximately $643 million of aggregate principal amount of 8.500% Senior Notes due 2027 will be redeemed.
  • Redemption date: November 30, 2026, following an irrevocable notice of redemption dated as of October 29, 2026.
  • Funding source: The redemption will be made using cash on hand, according to the filing.
  • CUSIP identifiers: The Notes carry CUSIP Nos. 91911XAW4 and U9098VAP7.
  • Indenture termination: The indenture pursuant to which the Notes were issued will be terminated in connection with the redemption.
  • Paying agent: The Bank of New York Mellon, 240 Greenwich Street, Floor 7E, New York, New York 10286, is named as the U.S. paying agent.

Bausch Health Americas to Retire 8.500% Senior Notes in Full

According to the filing, Bausch Health Companies Inc. (NYSE:BHC, TSX:BHC) disclosed that its subsidiary, Bausch Health Americas, Inc., will issue an irrevocable notice of redemption dated as of October 29, 2026. The redemption covers approximately $643 million of aggregate principal amount of outstanding 8.500% Senior Notes due 2027, identified by CUSIP Nos. 91911XAW4 and U9098VAP7. The company stated that the redemption will be funded using cash on hand.

The filing notes that payment of the redemption price and surrender of the Notes will be made through the facilities of the Depository Trust Company, in accordance with its applicable procedures. The Bank of New York Mellon, located at 240 Greenwich Street, Floor 7E, New York, New York 10286, is identified as the U.S. paying agent, with attention directed to Corporate Trust Administration. The notice of redemption will be issued to record holders of the Notes.

The filing further states that the indenture under which the Notes were issued will be terminated in connection with the redemption. The company included a clarification that nothing in the press release itself constitutes a formal notice of redemption of the Notes. The filing contains forward-looking statements that, as the company's cautionary language notes, "are neither historical facts nor assurances of future performance" and are subject to risks and uncertainties described in Bausch Health's filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators.

What Was Disclosed

Bausch Health Americas, Inc. disclosed plans to redeem approximately $643 million of 8.500% Senior Notes due 2027 on November 30, 2026, using cash on hand, with the associated indenture to be terminated upon completion of the redemption.